Happel David

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$63,730.70
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Happel David

According to the SEC Form 4 filings, Happel David, being in a position of

  1. President & CEO at Sagimet Biosciences Inc.,
    оver the last 12 months, has bought 12100 shares for $63,731, and sold 0 shares,
    over all time since 2024-03-26, has bought 12100 shares for $63,731, and sold 0 shares.

The largest purchase of all time was on 2024-03-26 and amounted to 12100 shares of Sagimet Biosciences Inc. for $63,731.

Biography of Happel David

No biography is available at this moment.

2024-03-26PurchaseSagimet Biosciences Inc.
SGMT
President & CEO
12,100
0.0365%
$5.27$63,731-19.12%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.